Skip to main content
logo
Hua Medicine (Shanghai) Ltd. (HKG:2552)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.590
+0.030 (1.17%)
Aug 27, 2026, 3:50 PM HKT

Hua Medicine (Shanghai) Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
654.41492.93255.8976.6117.6-
Revenue Growth
32.76%92.63%234.02%335.31%--
Gross Profit
396.85280.36124.7237.377.69-
Operating Income
-106.28-144.88-360.31-338.07-267.12-321.67
Net Income
-107.791,106-250.14-211.23-203.51-325.73
Earnings Per Share
-0.111.10-0.25-0.22-0.21-0.34
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,0731,0921,1401,461490.63675.24
Total Debt
354.26301.67300.18167.7597.5871.53
Net Cash (Debt)
718.68790.62839.571,293393.05603.71
Net Cash Growth
-9.10%-5.83%-35.07%228.98%-34.89%-36.54%
Net Cash Per Share
0.720.790.861.320.410.63

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-30.53-52.15-417.97889.37-230.11-272.98
Capital Expenditures
-7.55-7.55-2.83-9.74-4.56-20.2
Free Cash Flow
-38.08-59.7-420.8879.63-234.67-293.18
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
60.64%56.88%48.74%48.79%43.69%-
Operating Margin
-16.24%-29.39%-140.80%-441.28%-1517.80%-
Pretax Margin
-16.47%224.44%-97.75%-275.73%-1156.36%-
Profit Margin
-16.47%224.44%-97.75%-275.73%-1156.36%-
FCF Margin
-5.82%-12.11%-164.44%1148.19%-1333.44%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-2.47----
Forward PE
-16.0530.5430.5429.00-
P/FCF Ratio
---1.99--
PS Ratio
3.385.555.2622.85181.75-